» Articles » PMID: 35874912

QTc Interval is Associated with Atrial Fibrillation in Individuals with Metabolic Syndrome Phenotype

Overview
Journal Int J Gen Med
Publisher Dove Medical Press
Specialty General Medicine
Date 2022 Jul 25
PMID 35874912
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Manifestations of metabolic syndrome (MetS) carry risks for atrial fibrillation (AF). The study determined whether any electrocardiographic parameter can reflect increased AF risk in individuals with MetS.

Patients And Methods: From our University Hospital database, we examined the presence of AF and its correlation with MetS manifestations, renal function, lipid profiles, and electrocardiographic parameters (P wave duration, PR interval, QRS width, and QTc intervals). Between January 2008 and December 2015, data from 4479 adults (women 41.6% vs men 58.4%) were identified.

Results: The overall prevalence of AF was 12.4%, without sex differences (women, 12.8% vs men, 12.1%). Patients with AF were older (age 73.9 ± 11.8 vs non-AF 67 ± 13.5 years), with lower lipid levels (TG, total cholesterol, and LDL-cholesterol, all p < 0.0001), and at lower eGFR level (64.1 ± 30.9 vs non-AF 68.8 ± 41.4 mL/min/1.73m2, p < 0.0001). Besides, sex differences were present in all electrocardiographic parameters (all p < 0.05). Hypertension had the highest odds ratio (1.33; p = 0.026) for AF. Comparing AF to non-AF, the QTc of quartiles was significantly different (p < 0.0089). The shortest and longest QTc quartiles had an increased incidence of AF.

Conclusion: AF risk in patients with MetS phenotypes can be reflected by QTc quartiles.

Citing Articles

Prevalence of Metabolic Syndrome and Its Association with Cardiovascular Outcomes in Hospitalized Patients with Inflammatory Bowel Disease.

Njeim R, Pannala S, Zaidan N, Habib T, Rajamanuri M, Moussa E J Clin Med. 2024; 13(22).

PMID: 39598052 PMC: 11594857. DOI: 10.3390/jcm13226908.

References
1.
Alonso A, Yin X, Roetker N, Magnani J, Kronmal R, Ellinor P . Blood lipids and the incidence of atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis and the Framingham Heart Study. J Am Heart Assoc. 2014; 3(5):e001211. PMC: 4323837. DOI: 10.1161/JAHA.114.001211. View

2.
Hajhosseiny R, Matthews G, Lip G . Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic. Heart Rhythm. 2015; 12(11):2332-43. DOI: 10.1016/j.hrthm.2015.06.038. View

3.
Marcotte-Chenard A, Deshayes T, Ghachem A, Brochu M . Prevalence of the metabolic syndrome between 1999 and 2014 in the United States adult population and the impact of the 2007-2008 recession: an NHANES study. Appl Physiol Nutr Metab. 2019; 44(8):861-868. DOI: 10.1139/apnm-2018-0648. View

4.
Mohanty S, Mohanty P, Di Biase L, Bai R, Pump A, Santangeli P . Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol. 2012; 59(14):1295-301. DOI: 10.1016/j.jacc.2011.11.051. View

5.
Kirubakaran S, Chowdhury R, Hall M, Patel P, Garratt C, Peters N . Fractionation of electrograms is caused by colocalized conduction block and connexin disorganization in the absence of fibrosis as AF becomes persistent in the goat model. Heart Rhythm. 2014; 12(2):397-408. PMC: 4315883. DOI: 10.1016/j.hrthm.2014.10.027. View